A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo

Cancer Immunology, Immunotherapy

Volumn 61, Issue 5, 2012, Pages 677-687

  Lin, Jinpiao ^a   Huo, Rongfen ^a   Wang, Li ^a   Zhou, Zhou ^a   Sun, Yue ^a   Shen, Baihua ^a   Wang, Rongfang ^b   Li, Ningli ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai International Medical Zone Building 16   (China)

Author keywords

Breast cancer; Cysteine rich protein 61; MDA MB 231 cell line; Monoclonal antibody

Indexed keywords

CYSTEINE RICH PROTEIN 61; CYSTEINE RICH PROTEIN 61 MONOCLONAL ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ANTIBODY; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYR61 GENE; DOWN REGULATION; DRUG EFFICACY; DRUG TARGETING; ENZYME PHOSPHORYLATION; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYSTEINE-RICH PROTEIN 61; DOWN-REGULATION; EPITOPES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84862507547     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-1135-y     Document Type: Article

References (45)

1. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33(10):461-473
2. Brigstock DR (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20(2):189-206
3. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF (1998) CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95(11):6355-6360 (Pubitemid 28249016)
4. Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178(2):169-175
5. Menendez JA, Mehmi I, Griggs DW, Lupu R (2003) The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. Endocr Relat Cancer 10(2):141-152 (Pubitemid 36758643)
6. Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119(Pt 23):4803-4810 (Pubitemid 46017793)
7. Sampath D, Winneker RC, Zhang Z (2001) Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology 142(6):2540-2548 (Pubitemid 32473110)
8. Zhang Q, Wu J, Cao Q, Xiao L, Wang L, He D, Ouyang G, Lin J, Shen B, Shi Y, Zhang Y, Li D, Li N (2009) A critical role of Cyr61 in interleukin-17- dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Rheum 60(12): 3602-3612
9. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP (2004) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10(6):2072-2081 (Pubitemid 38375569)
10. Lin MT, Zuon CY, Chang CC, Chen ST, Chen CP, Lin BR, Wang MY, Jeng YM, Chang KJ, Lee PH, Chen WJ, Kuo ML (2005) Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/ cyclooxygenase -2 signaling pathway. Clin Cancer Res 11(16):5809-5820
11. D'Antonio KB, Toubaji A, Albadine R, Mondul AM, Platz EA, Netto GJ, Getzenberg RH (2010) Extracellular matrix associated protein CYR61 is linked to prostate cancer development. J Urol 183(4):1604-1610
12. Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J (2010) Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Res 70(7):2932-2941
13. Leask A (2010) A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells. J Cell Commun Signal 4(1):71-72
14. Grzeszkiewicz TM, Kirschling DJ, Chen N, Lau LF (2001) CYR61 stimulates human skin fibroblast migration through integrin alpha vbeta 5 and enhances mitogenesis through integrin alphavbeta 3, independent of its carboxyl-terminal domain. J Biol Chem 276(24):21943-21950
15. Xie D, Nakachi K, Wang H, Elashoff R, Koeffler HP (2001) Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features. Cancer Res 61(24):8917-8923 (Pubitemid 34013909)
16. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002) Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 21(53):8178-8185 (Pubitemid 35454421)
17. Hirschfeld M, zur Hausen A, Bettendorf H, Jager M, Stickeler E (2009) Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer. Cancer Res 69(5): 2082-2090
18. Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, Kuo ML (2004) Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 279(23):24015-24023
19. Monnier Y, Farmer P, Bieler G, Imaizumi N, Sengstag T, Alghisi GC, Stehle JC, Ciarloni L, Andrejevic-Blant S, Moeckli R, Mirimanoff RO, Goodman SL, Delorenzi M, Ruegg C (2008) CYR61 and alphavbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma. Cancer Res 68(18):7323-7331
20. Troester MA, Lee MH, Carter M, Fan C, Cowan DW, Perez ER, Pirone JR, Perou CM, Jerry DJ, Schneider SS (2009) Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res 15(22):7020-7028
21. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE (2005) Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11(16):6012-6019 (Pubitemid 41170333)
22. Jin Y, Kim HP, Cao J, Zhang M, Ifedigbo E, Choi AM (2009) Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death. FASEB J 23(2):341-350
23. Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327(2):125-130
24. Schober JM, Lau LF, Ugarova TP, Lam SC (2003) Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J Biol Chem 278(28):25808-25815 (Pubitemid 36835339)
25. Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R (2005) A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene 24(5):761-779 (Pubitemid 40216085)
26. Perbal B (2009) Alternative splicing of CCN mRNAs...it has been upon us. J Cell Commun Signal 3(2):153-157
27. O'Kelly J, Chung A, Lemp N, Chumakova K, Yin D, Wang HJ, Said J, Gui D, Miller CW, Karlan BY, Koeffler HP (2008) Functional domains of CCN1 (Cyr61) regulate breast cancer progression. Int J Oncol 33(1):59-67
28. Yokoyama WM (2001) Production of monoclonal antibodies. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (eds) Current protocols in immunology. John Wiley &Sons, New York, pp 2.5.1-2.5.17
29. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68(11):4311-4320
30. Mouridsen HT, Rose C, Brodie AH, Smith IE (2003) Challenges in the endocrine management of breast cancer. Breast 12(Suppl 2):S2-S19 (Pubitemid 40023558)
31. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massague J (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7):1315-1326
32. Xie D, Yin D, Tong X, O'Kelly J, Mori A, Miller C, Black K, Gui D, Said JW, Koeffler HP (2004) Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/lef signaling pathways. Cancer Res 64(6): 1987-1996 (Pubitemid 38339444)
33. Vellon L, Menendez JA, Lupu R (2005) AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene 24(23):3759-3773 (Pubitemid 40826875)
34. Gery S, Xie D, Yin D, Gabra H, Miller C, Wang H, Scott D, Yi WS, Popoviciu ML, Said JW, Koeffler HP (2005) Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res 11(20): 7243-7254 (Pubitemid 41507681)
35. Denys H, De Wever O, Nusgens B, Kong Y, Sciot R, Le AT, Van Dam K, Jadidizadeh A, Tejpar S, Mareel M, Alman B, Cassiman JJ (2004) Invasion and MMP expression profile in desmoid tumours. Br J Cancer 90(7):1443-1449 (Pubitemid 38590640)
36. Pendurthi UR, Tran TT, Post M, Rao LV (2005) Proteolysis of CCN1 by plasmin: functional implications. Cancer Res 65(21): 9705-9711 (Pubitemid 41541446)
37. Pearce EG, Laxton RC, Pereira AC, Ye S (2007) Haplotype effects on matrix metalloproteinase-1 gene promoter activity in cancer cells. Mol Cancer Res 5(3):221-227 (Pubitemid 46569774)
38. Nguyen N, Kuliopulos A, Graham RA, Covic L (2006) Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res 66(5):2658-2665
39. Butler GS, Dean RA, Tam EM, Overall CM (2008) Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Mol Cell Biol 28(15):4896-4914
40. Minn AJ, Gupta GP, Siegel PM, Bos PD, ShuW, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J (2005) Genes that mediate breast cancer metastasis to lung. Nature 436(7050):518-524 (Pubitemid 41112921)
41. Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massague J (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005-1009
42. Fong KM, Kida Y, Zimmerman PV, Smith PJ (1996) TIMP1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res 2(8):1369-1372 (Pubitemid 26299436)
43. Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O (1997) High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases. Clin Cancer Res 3(9):1623-1628 (Pubitemid 27431572)
44. Bhuvarahamurthy V, Kristiansen GO, Johannsen M, Loening SA, Schnorr D, Jung K, Staack A (2006) In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep 15(5):1379-1384
45. Sampieri CL, Nuttall RK, Young DA, Goldspink D, Clark IM, Edwards DR (2008) Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes. Matrix Biol 27(2):128-138 (Pubitemid 351221010)